TNF and acute myeloid leukemia: Interestingly, treatment with the GSK-3 inhibitors SB415286, LY-2090314, or Tideglusib, or the genetic inactivation of one or the other of the GSK-3 isoforms, enhanced the ability of NK cells to kill AML cells, also due to increased tumor necrosis factor α (TNF-α) levels.